Kirk Allen Coleman Tff Pharmaceuticals, Inc. (TFFP) insider trading activity

Kirk Allen Coleman is Chief Financial Officer of TFF Pharmaceuticals, Inc.. Currently has a direct ownership of 45,859 shares of TFFP, which is worth approximately $16,050. The most recent transaction as insider was on Jul 03, 2024, when has been sold 10,184 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 45.9K

0% 3M change

28.55% 12M change

Total Value Held $16,050

KIRK ALLEN COLEMAN Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Jul 03 2024	BUY Grant, award, or other acquisition	-	10,184 Added 18.17%	45,859 Common Stock
Aug 15 2023	BUY Open market or private purchase	$5,000 $0.25 p/Share	20,000 Added 35.92%	35,675 Common Stock
Mar 10 2023	BUY Open market or private purchase	$9,480 $0.79 p/Share	12,000 Added 43.36%	15,675 Common Stock
May 17 2022	BUY Open market or private purchase	$2,053 $4.83 p/Share	425 Added 10.37%	3,675 Common Stock
May 16 2022	BUY Open market or private purchase	$5,500 $4.4 p/Share	1,250 Added 27.78%	3,250 Common Stock
Sep 16 2021	BUY Open market or private purchase	$7,300 $7.3 p/Share	1,000 Added 33.33%	2,000 Common Stock
Mar 15 2021	SELL Open market or private sale	$85,250 $17.05 p/Share	5,000 Reduced 83.33%	1,000 Common Stock
Mar 15 2021	BUY Exercise of conversion of derivative security	$12,500 $2.5 p/Share	5,000 Added 45.45%	6,000 Common Stock
Feb 16 2021	SELL Open market or private sale	$84,100 $16.82 p/Share	5,000 Reduced 83.33%	1,000 Common Stock
Feb 16 2021	BUY Exercise of conversion of derivative security	$12,500 $2.5 p/Share	5,000 Added 45.45%	6,000 Common Stock
Jan 15 2021	SELL Open market or private sale	$87,500 $17.5 p/Share	5,000 Reduced 83.33%	1,000 Common Stock
Jan 15 2021	BUY Exercise of conversion of derivative security	$12,500 $2.5 p/Share	5,000 Added 45.45%	6,000 Common Stock
Dec 23 2020	SELL Open market or private sale	$152,400 $15.24 p/Share	10,000 Reduced 90.91%	1,000 Common Stock
Dec 23 2020	BUY Exercise of conversion of derivative security	$25,000 $2.5 p/Share	10,000 Added 47.62%	11,000 Common Stock
Nov 10 2020	SELL Open market or private sale	$226,800 $15.12 p/Share	15,000 Reduced 93.75%	1,000 Common Stock
Nov 10 2020	BUY Exercise of conversion of derivative security	$37,500 $2.5 p/Share	15,000 Added 48.39%	16,000 Common Stock

KAC

Kirk Allen Coleman

Chief Financial Officer

Austin, TX

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells TFFP shares.

Notify only if

Value

Insider Trading

Get notified when an Tff Pharmaceuticals, Inc. insider buys or sells TFFP shares.

Notify only if

Operation

Value

Type

News

Receive news related to TFF Pharmaceuticals, Inc.

Track Activities on TFFP

Account